These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26394118)
1. Effect of Irbesartan on Chemerin in the Renal Tissues of Diabetic Rats. Yu QX; Zhang H; Xu WH; Hao F; Liu SL; Bai MM; Mu JW; Zhang HJ Kidney Blood Press Res; 2015; 40(5):467-77. PubMed ID: 26394118 [TBL] [Abstract][Full Text] [Related]
2. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade. Bonnet F; Candido R; Carey RM; Casley D; Russo LM; Osicka TM; Cooper ME; Cao Z J Hypertens; 2002 Aug; 20(8):1615-24. PubMed ID: 12172324 [TBL] [Abstract][Full Text] [Related]
3. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney. Anjaneyulu M; Chopra K Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells. Liu BC; Chen L; Sun J; Huang HQ; Ma KL; Liu H; Liu DG; Zhang XL Nephron Exp Nephrol; 2006; 103(1):e16-26. PubMed ID: 16374037 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy. Tunçdemir M; Öztürk M Metabolism; 2016 Oct; 65(10):1466-77. PubMed ID: 27621182 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats. Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232 [TBL] [Abstract][Full Text] [Related]
7. Effects of blocking the renin-angiotensin system on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats. Zhang L; Ma J; Gu Y; Lin S Nephron Exp Nephrol; 2006; 104(3):e103-11. PubMed ID: 16837815 [TBL] [Abstract][Full Text] [Related]
8. Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye. Prasad T; Roksnoer LC; Zhu P; Verma A; Li Y; Batenburg WW; de Vries R; Danser AH; Li Q Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6722-6730. PubMed ID: 27951594 [TBL] [Abstract][Full Text] [Related]
9. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585 [TBL] [Abstract][Full Text] [Related]
10. [Effects of irbesartan on renal advanced glycation end products and their receptor in rats with early diabetic nephropathy]. Long HB; Niu HX; Li XY; Zhou WD; He JH; Zhong J; Wei LB Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2433-6, 2441. PubMed ID: 20034895 [TBL] [Abstract][Full Text] [Related]
11. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats. Ren X; Guan G; Liu G; Liu G Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061 [TBL] [Abstract][Full Text] [Related]
12. Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor. Zhou A; Yu L; Li J; Zhang J; Wang H Hypertens Res; 2000 Jul; 23(4):391-7. PubMed ID: 10912779 [TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats. Hu W; Yu Q; Zhang J; Liu D Inflammation; 2012 Aug; 35(4):1287-93. PubMed ID: 22350950 [TBL] [Abstract][Full Text] [Related]
14. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats]. Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713 [TBL] [Abstract][Full Text] [Related]
15. Renoprotection and renin-angiotensin system blockade in diabetes mellitus. Ruilope LM Am J Hypertens; 1997 Dec; 10(12 Pt 2):325S-331S. PubMed ID: 9438777 [TBL] [Abstract][Full Text] [Related]
16. Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model. Liu X; Xu Q; Wang X; Zhao Z; Zhang L; Zhong L; Li L; Kang W; Zhang Y; Ge Z Pharmacol Res; 2015 Mar; 93():43-51. PubMed ID: 25617729 [TBL] [Abstract][Full Text] [Related]
17. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy]. Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045 [TBL] [Abstract][Full Text] [Related]
18. [Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats]. Li S; Cao B; Feng QH; Li XZ Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):817-21. PubMed ID: 14728886 [TBL] [Abstract][Full Text] [Related]
19. Effects of irbesartan on the expression of matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 in streptozotocin-induced diabetic rat kidney. Liu BC; Xu Y; Ma KL; Huang HQ; Yin LF; Liu DG Chin Med J (Engl); 2005 Jun; 118(12):1040-4. PubMed ID: 15978215 [No Abstract] [Full Text] [Related]
20. An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy. García-Donaire JA; Segura J; Ruilope LM Expert Opin Pharmacother; 2005 Aug; 6(9):1587-96. PubMed ID: 16086646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]